Cargando…
Clusterin accumulates in synapses in Alzheimer’s disease and is increased in apolipoprotein E4 carriers
One of the major challenges in developing effective therapeutic strategies for Alzheimer’s disease is understanding how genetic risk factors contribute to neurodegeneration. The apolipoprotein epsilon 4 isoform (APOE4) and variants in the Clusterin (CLU) gene (also known as apolipoprotein J) are ass...
Autores principales: | Jackson, Rosemary J, Rose, Jamie, Tulloch, Jane, Henstridge, Chris, Smith, Colin, Spires-Jones, Tara L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904249/ https://www.ncbi.nlm.nih.gov/pubmed/31853523 http://dx.doi.org/10.1093/braincomms/fcz003 |
Ejemplares similares
-
Clusterin/apolipoprotein J, its isoforms and Alzheimer's disease
por: Milinkeviciute, Giedre, et al.
Publicado: (2023) -
Alzheimer's disease: synapses gone cold
por: Koffie, Robert M, et al.
Publicado: (2011) -
Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype
por: Hesse, Raphael, et al.
Publicado: (2019) -
Spread of tau down neural circuits precedes synapse and neuronal loss in the rTgTauEC mouse model of early Alzheimer's disease
por: Pickett, Eleanor K., et al.
Publicado: (2017) -
Reducing voltage-dependent potassium channel Kv3.4 levels
ameliorates synapse loss in a mouse model of Alzheimer’s
disease
por: Yeap, Jie, et al.
Publicado: (2022)